Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD.
Journal
Indian pacing and electrophysiology journal
ISSN: 0972-6292
Titre abrégé: Indian Pacing Electrophysiol J
Pays: Netherlands
ID NLM: 101157207
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
received:
16
11
2023
revised:
12
08
2024
accepted:
22
10
2024
medline:
27
10
2024
pubmed:
27
10
2024
entrez:
26
10
2024
Statut:
aheadofprint
Résumé
Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a real-life collective of patients with an ICD, especially regarding ICD-therapies. NT-proBNP was assessed in plasma and fresh spot urine (the latter related to urinary creatinine) from 322 patients of our ICD outpatient clinic. 54 healthy individuals served as a control group. Follow-up regarding mortality and ICD therapies was performed after 32 months (IQR 5- 35 months). Plasma and urinary NT-proBNP was positively correlated (r=0.89, p<0,001). According to ROC analysis urinary NT-proBNP detected LV dysfunction (EF<35% vs. healthy CTRL) with very satisfying predictive values (AUC 0.95), but plasma NT-proBNP showed slightly better values (AUC 0.99). Patients who received appropriate ICD-shock-therapies showed significantly higher plasma (p<0.001) as well as urinary NT-proBNP levels (p=0.011) compared to patients without shock-therapy. In Kaplan-Meier analysis, plasma as well as urinary NT-proBNP levels > Youden-Index showed significantly higher event rates for appropriate ICD-shock therapies (p<0.001 and p=0.016) and the combined endpoint of all-cause-mortality and shock therapies (each p<0.001). Urinary and plasma NT-proBNP were independent predictors for appropriate ICD-shock-therapies and for the combined endpoint of all-cause mortality and appropriate ICD-shock-therapies (each p<0.001). Urinary NT-proBNP as a marker for LV dysfunction and symptomatic heart failure showed promising predictive values. Associations between plasma as well as urinary NT-proBNP and ICD shock-therapies could be shown.
Identifiants
pubmed: 39461716
pii: S0972-6292(24)00150-5
doi: 10.1016/j.ipej.2024.10.006
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2024 Indian Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.